Please login to the form below

Not currently logged in

Ex-Pfizer chief Kindler joins venture capital firm

Takes up role as venture partner at Lux Capital

Lux Capital Pfizer Jeff KindlerPfizer's former CEO and chairman Jeff Kindler has joined venture capital firm Lux Capital as a venture partner.

The New York-based firm said Kindler would help identify new healthcare investment opportunities and work with its portfolio of companies.

“With tremendous leadership experience in the healthcare industry, Jeff has an appreciation for the intersection of novel science, product development and commercial transactions,” said Robert Paull, managing partner at Lux Capital.

“As Lux continues to make new investments at the cutting edge of healthcare and as our life sciences portfolio matures, Jeff will prove to be an invaluable resource."

Kindler, whose current roles include acting as senior advisor to global investment company Paragon Pharmaceuticals, left Pfizer in 2010 after four years at the helm.

“I have great respect for the work Lux Capital is doing to build and back companies addressing some of healthcare's biggest challenges,” said Kindler. “It's a great group, and I look forward to being actively involved across the portfolio.”

Kindler has previously served as chairman of PhRMA (Pharmaceutical Researchers and Manufacturers of America) and, prior to joining Pfizer in 2002, he held senior legal roles at the General Electric Company and McDonald's Corporation

13th August 2012


Featured jobs

Subscribe to our email news alerts


Add my company

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge